Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Hempdocon Jun 12, 2020 1:11am
192 Views
Post# 31141876

RE:RE:RE:RE:RE:RE:RE:RE:RE:Bladder Cancer Clinical Trials

RE:RE:RE:RE:RE:RE:RE:RE:RE:Bladder Cancer Clinical Trials

Yajne wrote:

" I agree that Dr. Kamat might be 'exactly what the doctor ordered'. his infamous quote at the early conclusion of the Ph1b trial, but I'm not buying it now. Since then Dr. Kamat has been 'absent', despite many opportunities to mention TLD1433.  He seems to have acted in every way to completely ignore TLT's activity, including the fact that Ph2 is underway. Even a glimmer of interest from Dr. Kamat could have some influence, but IMO his 'deal' with his big Pharma sugar-daddy would likely prevent that. Expect him to come out once again when Ph2 results are blatantly obvious, but his absence has definitely prolonged that occurance, likely another delay tactic. So no, I'm not buying his limp response to your exchange with him. JMHO"

I wish I could have had an exchange with him...think that was Enrique.

 

At least we have 4/5 boxes checked...
 

1). Know your advantage...check
2). Know your competition...check
3). Keep your competition close...check
4). Fight the competition where they aren't...check
5). Be victorious....soon to be checked.


 

Bullboard Posts